简介
Professor Kelvin Yeung is a distinguished scholar in the field of orthopaedic biomaterial research, with a particular emphasis on the design of orthopaedic biomaterials, antibacterial nanomaterials, 3D bioprinting, and musculoskeletal tissue engineering. He earned his bachelor’s degree in materials science before advancing to attain both a master’s degree and a PhD in orthopaedic science from the University of Hong Kong’s Medical Faculty. Throughout his career, he has dedicated his research to critical areas such as bone-to-implant osseointegration, bone regeneration, and the development of antibacterial treatments.
Professor Yeung currently serves as the Dean of Student Affairs of the university and is also a tenured full professor, holding the Ng Chun-Man Professorship in Orthopaedic Bioengineering. He leads the research division and acts as the departmental research and postgraduate advisor within the Department of Orthopaedics and Traumatology at the School of Clinical Medicine, LKS Faculty of Medicine (HKUMed), The University of Hong Kong. His academic stature is further amplified by honorary appointments as the Director (HKU) of the Chinese Academy of Sciences Shenzhen-Hong Kong Joint Laboratory for Biomaterials, a Professor in the Department of Orthopaedics at Zhongshan Hospital, and as Principal Researcher in the Institute of Spinal Tumor at Fudan University. His scholarly impact is evident, with an impressive h-index of 90 according to Scopus, reflecting over 29,553 citations, while his Google Scholar metrics reveal an h-index of 101 with more than 34,700 citations and an i10-index of 296. Honourably, he has been identified as one of the Highly Cited Researchers for 2023 to 2025 (cross-field), Highly Ranked Scholar 2022 (Prior Five Years) in the field of Medicine by ScholarGPS (Global ranking: #7 in Biomaterial; #14 in Antibacterial activity; #16 in Orthopaedic Surgery), and he ranks among the Top 1% of scholars worldwide in biomaterials, as recognized by Clarivate Analytics’ Essential Science Indicators (ESI) since 2014, and the Top 2% Scientists in standardized citation indicators (Biomedical Engineering) since 2021. In 2026, he was positioned at #1346 globally and #440 in China in the category of materials science by Research.com.
Beyond a robust publication record, including over 330 peer-reviewed SCI journal articles and 47 filed patents in various jurisdictions, Professor Yeung co-founded OrthoSmart Limited and NeurOssence Bio Limited with his colleagues, effectively bridging the gap between research and clinical application. He also serves as a consultant for several publicly listed medical and biomaterials companies in Hong Kong.
Throughout his illustrious career, Professor Yeung has actively engaged in numerous local and regional competitions, garnering accolades such as the Fudan Scholar (2024), Young Scientist Award (2005), Young Engineer Award (2009), and Faculty Research Output Award (2019, 2023 & 2025). In recent years, he was elected as Fellow (International) of American Institute of Medical and Biological Engineering, Fellow of International Academy of Medical and Biological Engineering and Fellow of the International Association of Advanced Materials. As both principal investigator and co-principal investigator, he has successfully secured funding exceeding HK$101,600,000. A fervent advocate for diversity, equity, and inclusion, he has trained 7 postdoctoral researchers, 30 PhD students, 19 Master’s students, and 4 undergraduate students, with over 50% representing female, African, or Middle-Eastern backgrounds. His contributions to the scientific community are substantiated by more than 40 awards from various local and international competitions and conferences, alongside invitations to deliver over 90 plenary lectures, keynotes, and invited talks at prestigious conferences.
In addition to his research and teaching commitments, Professor Yeung plays an active role in several local and international academic organizations. He serves as Associate Editor for the “Bioactive Materials Journal” (impact factor: 20.3, ranking #2 out of 55 in materials science) and; #2 out of 123 in engineering (biomedical)), is a founding member and current President of the Chinese Association for Biomaterials (CAB), and chairs the Orthopaedic Biomaterials section of the Society for Biomaterials (SFB) USA. He previously acted as Secretary and Treasurer of CAB and Vice-Chair of SFB Orthopaedic Biomaterials. Moreover, he had been appointed as the Associate Dean of Student Affairs for the Centre of Development and Resources for Students (CEDARS) by the University, where he oversees student education development.
[Updated 18th May 2026]
